Inventor
SALA EVIS
US3 patents
Patents
3 patentsUS10413533B2Sep 17, 2019
Enhancement of tumor response to chemotherapy by activation of the ASMase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent
MEMORIAL SLOAN KETTERING CANCER CENTER1 citations67
US12036212B2Jul 16, 2024
Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent
MEMORIAL SLOAN KETTERING CANCER CENTER0 citations57
US11285137B2Mar 29, 2022
Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent
MEMORIAL SLOAN KETTERING CANCER CENTER0 citations57